S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

LGND Ligand Pharmaceuticals Incorporated

118.11

0.83 (0.71%)

29 Jan 2025 - Closed

Delayed by 15 minutes

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Ligand Pharmaceuticals (NASDAQ:LGND)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Ligand Pharmaceuticals Charts.

Ligand Pharmaceuticals (NASDAQ:LGND)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Ligand Pharmaceuticals Charts.

Ligand Pharmaceuticals Incorporated News

Ligand Hosts 2024 Investor and Analyst Day and Introduces 2025 Guidance
Wednesday 11 December 2024 (2 months ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 7 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 3 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 28 November 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

Ligand to Present at Stifel 2024 Healthcare Conference
Friday 15 November 2024 (2 months ago) • Business Wire

Form 144 - Report of proposed sale of securities
Wednesday 13 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Saturday 9 November 2024 (3 months ago) • Edgar (US Regulatory)

Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer
Thursday 17 October 2024 (3 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 26 September 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 25 September 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 25 September 2024 (4 months ago) • Edgar (US Regulatory)

More Ligand Pharmaceuticals Incorporated News Articles

Gold vs US Dollar

AUD vs US Dollar

Australia And New Zealan...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions